3-Bromo-2-methyl-benzenesulfonyl chloride, 95.0%, 1g

3,4-Dimethoxy-�-nitrostyrene, 98.0%, 25g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-propoxypropanoic acid, 98%, 250mg

2-Thioxo-1,2-dihydropyridine-3-carboxamide, 98%, 250mg

2-Hydroxy-[1,1'-biphenyl]-4,4'-dicarboxylic acid, 98%, 1g

Ethyl 3,5-difluoropyridine-2-carboxylate, 98+%, 1g

6-PHENYL-1H-INDAZOLE, 95%, 250mg

(R)-Acetylamino-cyclohexyl-acetic acid, 97.0%, 1g

2-BROMO-3-ETHYNYLPYRIDINE, 95%, 100mg

(2R,3R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-hydroxy-3-phenylpropanoic acid, 95+%, 250mg

Alfuzosin Hydrochloride>98.0%(HPLC)1g

GC-Kapillarsäule ROTI®Cap-5, unpolar, L 50 m, Ø-Innen 0,20 mm, Filmd. 0,35 µm, 1 Stück

2-((Tetrahydro-2H-pyran-4-yl)oxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 95.0%, 5g